Delivery Order SPE2DB22D2211-SPE2DB25FSBDF
- Not listed
- The Defense Logistics Agency awarded a $3,682.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of July 22, 2025. This non-set-aside competitive award will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. This delivery order executes under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,007.80 for NovoLog 100 Unit/ML FlexPen 3ML insulin pens on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract for pharmaceutical supply to support federal medical needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,568.36 to AmerisourceBergen Drug Corp for the supply of Novolog 100 Unit/ML FlexPen 3ML insulin pens. This firm fixed-price, non-set-aside contract was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The rapid completion timeline reflects the expedited nature of this medical supply delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,437.90 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of July 22, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on July 21, 2025, with performance taking place at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,108.70 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The award was made on July 21, 2025, with an ultimate completion date of July 22, 2025, using firm fixed-price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this delivery from its corporate office location. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $4,406.16 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $1,405.80 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively as a child contract under AmerisourceBergen's larger DLA prime vendor contract vehicle. The place of performance is listed as...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,354.70 to provide NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This order is being fulfilled under an indefinite delivery contract (IDC) previously awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
- The Defense Logistics Agency awarded a $1,781.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562331403 Novolog 100 unit/ml FlexPen 3ml insulin delivery devices. The delivery order was issued under an existing prime vendor contract vehicle and calls for the delivery of the specified insulin pens to a facility located in Conshohocken, Pennsylvania by September 28, 2023. As a leading provider of medical supplies and pharmaceuticals to the Department of...
- The Defense Logistics Agency awarded a $7,509.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561836509 units of NovoLog insulin flex pens. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for Amerisourcebergen to provide 3 milliliter NovoLog insulin flex pens to support the DLA's medical supply needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBDFDelivery Order
The Defense Logistics Agency (DLA) awarded a $8,495.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a completion date of July 21, 2025. This non-set-aside contract was competitively awarded on July 18, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal healthcare needs, specifically for diabetes management medications. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle valued through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies comprehensive pharmaceutical products and medical supplies to support military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 7/18/25 |